Liver damage and hepatotropic virus infections in drug addicts
Laskus, T.
Wiadomosci Lekarskie 45(15-16): 615-618
1992
ISSN/ISBN: 0043-5147 PMID: 1488832 Document Number: 404896
Document emailed within 1 workday
Related Documents
El-Ghazzawi, E.; Drew, L.; Hamdy, L.; El-Sherbini, E.; Sadek, S.e.-D.; Saleh, E. 1995: Intravenous drug addicts: a high risk group for infection with human immunodeficiency virus, hepatitis viruses, cytomegalo virus and bacterial infections in Alexandria Egypt Journal of the Egyptian Public Health Association 70(1-2): 127-150Sukhanov, D.S.; Vinogradova, T.I.; Zabolotnykh, N.V.; Vitovskaia, M.L.; Kovalenko, A.L. 2014: The hepatotropic activity of runihol and ademethionine against experimental liver damage caused by first-line antituberculosis drugs Arkhiv Patologii 76(2): 26-30
Tamarkina, A.D.; Neverov, I.V.; Turitsyna, I.G.; Dement'eva, E.S.; Krylova, N.I. 1985: Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases Sovetskaia Meditsina 12: 26-30
Breithaupt, H. 1994: Drug-induced liver damage caused by antirheumatic drugs--antirheumatic therapy in pre-existing liver damage Zeitschrift für Rheumatologie 53(4): 250-254
Titti, F.; Lazzarin, A.; Costigliola, P.; Oliva, C.; Nicoletti, L.; Negri, C.; Ricchi, E.; Donati, G.; Uberti-Foppa, C.; Re, M.C. 1987: Human immunodeficiency virus (HIV) seropositivity in intravenous (i.v.) drug abusers in three cities of Italy: possible natural history of HIV infection in I.v. drug addicts in Italy Journal of Medical Virology 23(3): 241-248
Titti, F.; Lazzarin, A.; Costigliola, P.; Oliva, C.; Nicoletti, L.; Negri, C.; Ricchi, E.; Donati, G.; Uberti-Foppa, C.; Re, M.C. 1987: Human immunodeficiency virus (HIV) seropositivity in intravenous (i.v.) drug abusers in three cities of Italy: possible natural history of HIV infection in I.v. drug addicts in Italy Journal of Medical Virology 23(3): 241-248
Helmstaedt, D.; May, B. 1975: Liver disease in drug addicts: frequency epidemiology and social importance International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 46-49
Heilmann, K.; Höpker, W.; Linhart, P.; Weizel, A. 1972: Comparative morphological studies of liver biopsies from drug addicts and users Verhandlungen der Deutschen Gesellschaft für Pathologie 56: 494-497
Demel, I.; Kryspin-Exner, K. 1973: Personality changes in alcoholics and drug addicts. Structural analysis of addictive processes in alcoholics and drug addicts Fortschritte der Medizin 91(35): 1379-1381
Pachón, J.; Viciana, P.; Cisneros, J.M.; García Pesquera, F.; Castillo, J.R.; Cañas, E. 1993: Pharmacokinetic study of zidovudine in parenteral drug addicts with human immunodeficiency virus infection Medicina Clinica 100(2): 46-49
Muga, R.; Tor, J.; Solsona, L.; Villanueva, C.; Pol, M.; Jacas, C.; Sabriá, M.; Rey-Joly, C.; Foz, M. 1991: Immunoglobulin a and human immunodeficiency virus type 1 infection in parenteral drug abuse addicts Medicina Clinica 96(10): 361-363
Verdejo, C.; Fernández Guerrero, M.L.; Castrillo, J.M.; Fernández Clúa, M.A.; Díaz Curiel, M.; de Villalobos, E. 1989: Endocarditis caused by Staphylococcus aureus in drug addicts and non-addicts: the same microbe in 2 diseases Revista Clinica Espanola 185(3): 123-127
Steentoft, A.; Kaa, E.; Simonsen, K.W.; Kringsholm, B.; Worm, K.; Hansen, A.C.; Toft, J.; Dragsholt, C. 1994: Deaths among drug addicts in Denmark. A forensic medical study of deaths among drug addicts during the period 1991-1992 related to the period 1984-1985 Ugeskrift for Laeger 156(42): 6215-6219
Muga, R.; Tor, J.; Soriano, V.; Clotet, B.; Ribera, A.; Ginestá, C.; Melús, R.; Rey-Joly, C.; Foz, M.; Ribas-Mundó, M. 1988: Human immunodeficiency virus antigens and antibodies in parenteral drug addicts: correlations with a clinical study Medicina Clinica 91(8): 286-288
Nett, H.H. 1975: Management of chronic inflammatory and toxic metabolic liver lesions in juvenile drug addicts and alcoholics using hepsan Die Medizinische Welt 26(51): 2305-2308
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Stefania Varani and Maria P. Landini 2002: Cytomegalovirus as a Hepatotropic Virus Clinical Laboratory 48(1-2): 39-44
May, B.; Helmstaedt, D. 1975: Liver disease in drug addicts: clinical course-toxicological and clinical pharmacological aspects International Journal of Clinical Pharmacology and Biopharmacy 12(1-2): 50-56
Taguchi, K.; Aishima, S.; Tsuneyoshi, M. 2006: Mechanism of biliary carcinogenesis: Hepatotropic hepatis virus Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 362-365
Somova, M.N.; Muzalevskaia, E.N.; Nikolaevskiĭ, V.A.; Buzlama, A.V.; Batishcheva, G.A.; Chernov, I.N. 2013: Drug-induced liver damage and the problem of its pharmacological correction Eksperimental'naia i Klinicheskaia Farmakologiia 76(9): 38-43